Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$794K Buy
+6,295
New +$800K 0.24% 113
2015
Q3
Sell
-5,635
Closed -$633K 412
2015
Q2
$586K Hold
5,635
0.48% 80
2015
Q1
$622K Buy
5,635
+325
+6% +$35.3K 0.52% 77
2014
Q4
$553K Buy
5,310
+295
+6% +$29.5K 0.47% 86
2014
Q3
$482K Sell
5,015
-260
-5% -$23.5K 0.44% 85
2014
Q2
$482K Buy
5,275
+225
+4% +$20.2K 0.48% 79
2014
Q1
$444K Hold
5,050
0.42% 98
2013
Q4
$468K Buy
5,050
+150
+3% +$13.5K 0.42% 88
2013
Q3
$400K Buy
+4,900
New +$414K 0.61% 75

Other funds holding CLX

Carnick & Kubik's CLX Position: Q1 2016 in Review

Carnick & Kubik opened a new position in Clorox (CLX) in Q1 2016: 6,295 shares worth $794K. The stake represents 0.24% of the portfolio and ranks #113 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in CLX as recently as Q2 2015.

Carnick & Kubik first reported a position in CLX in Q3 2013 and has held it in 9 quarters since. 853 funds tracked by Wall St. Rank hold CLX as of Q1 2016.

  • Carnick & Kubik held 6,295 shares of Clorox worth $794K as of Q1 2016.
  • Clorox was a new Carnick & Kubik position in Q1 2016.
  • Clorox made up 0.24% of Carnick & Kubik's portfolio in Q1 2016, its #113 holding.
  • Carnick & Kubik first reported a position in Clorox in Q3 2013 and has held it in 9 quarters since.
  • 853 funds tracked by Wall St. Rank held Clorox as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.